NANOG and neoplasm: To this end, we performed a double-blind analysis of GLI1 and NANOG expression in a previously described set of tissue microarrays (TMA) with multiple tumor cores from 116 ERMS patient samples using immunohistochemistry.22 Reliable protein expression status was obtained for 91 patients, most of whom were negative for both proteins.